Immuron Ltd Files April 2024 Report on Form 6-K
Ticker: IMRN · Form: 6-K · Filed: Apr 23, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed its monthly 6-K with the SEC on 4/23, standard reporting for foreign issuers.
AI Summary
Immuron Limited filed a Form 6-K on April 23, 2024, reporting its activities for the month of April 2024. The filing indicates that the company is a foreign private issuer and is furnishing information to the SEC. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Immuron Limited's regulatory reporting to the SEC, which is important for investors tracking the company's compliance and information dissemination.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain new material financial or operational information that would typically increase risk.
Key Numbers
- 001-38104 — Commission File Number (Identifies Immuron Limited's filing with the SEC.)
Key Players & Entities
- Immuron Limited (company) — Registrant
- United States Securities and Exchange Commission (company) — Regulatory Body
- April 2024 (date) — Reporting Period
- 001-38104 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing for Immuron Limited?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
What reporting period does this Form 6-K cover?
This Form 6-K covers the month of April 2024.
Is Immuron Limited filing an annual report on Form 20-F or 40-F?
The filing indicates that Immuron Limited files annual reports under cover of Form 20-F.
Does Immuron Limited furnish information under Rule 12g3-2(b)?
No, the filing explicitly states 'No' for furnishing information under Rule 12g3-2(b).
What is Immuron Limited's principal executive office address?
Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Stats: 318 words · 1 min read · ~1 pages · Grade level 18.6 · Accepted 2024-04-23 06:06:53
Filing Documents
- ea0204462-6k_immuron.htm (6-K) — 14KB
- ea020446201ex99-1_immuron.htm (EX-99.1) — 37KB
- image_001.jpg (GRAPHIC) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 679KB
- ex99-1_002.jpg (GRAPHIC) — 990KB
- ex99-1_003.jpg (GRAPHIC) — 347KB
- ex99-1_004.jpg (GRAPHIC) — 568KB
- ex99-1_005.jpg (GRAPHIC) — 822KB
- ex99-1_006.jpg (GRAPHIC) — 810KB
- ex99-1_007.jpg (GRAPHIC) — 1059KB
- ex99-1_008.jpg (GRAPHIC) — 873KB
- ex99-1_009.jpg (GRAPHIC) — 391KB
- ex99-1_010.jpg (GRAPHIC) — 836KB
- ex99-1_011.jpg (GRAPHIC) — 743KB
- ex99-1_012.jpg (GRAPHIC) — 889KB
- ex99-1_013.jpg (GRAPHIC) — 622KB
- ex99-1_014.jpg (GRAPHIC) — 714KB
- ex99-1_015.jpg (GRAPHIC) — 414KB
- ex99-1_016.jpg (GRAPHIC) — 1263KB
- 0001213900-24-035096.txt ( ) — 16612KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on April 23, 2024 titled: - “Immuron CEO Steven Lydeamore to present at The Watchlist” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO Steven Lydeamore to present at The Watchlist 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: April 23, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3